Copanlisib dihydrochloride
CAS: 1402152-13-9
Ref. 3D-CGC15213
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Product Information
Copanlisib is a small molecule that targets the PI3K-Akt pathway. It has been shown to be an effective treatment for cancer cells with the PD-L1 protein. Copanlisib is a pan-PI3K inhibitor, which means it inhibits all three isoforms of the enzyme: PI3Kα, PI3Kβ, and PI3Kγ. Copanlisib has shown clinical efficacy in patients with advanced solid tumours who are resistant to other treatments. This drug has also been shown to have hepatotoxic effects in mice, although this effect was not observed in humans.
Chemical properties
Technical inquiry about: 3D-CGC15213 Copanlisib dihydrochloride
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
